SCHEMBL4383265

SCHEMBL4383265

C1=CCC2(CC1)OCCO2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16564664 0.78
SCHEMBL253464 0.71 NPC1 (0.32)
SCHEMBL10009873 0.70
SCHEMBL943487 0.69
SCHEMBL10774939 0.67
SCHEMBL5331066 0.65
SCHEMBL3623472 0.65
SCHEMBL15526324 0.65
SCHEMBL27438121 0.65
SCHEMBL1809810 0.64 L3MBTL1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3960741-A1 QUINOLINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF Academy Of Military Medical Sciences (CN) 2022-03-02 EP claimed
EP-2170350-B1 SUBSTITUTED IMIDAZOHETEROCYCLES CARA THERAPEUTICS INC (US) 2013-09-11 EP claimed
CN-112142747-B Pyrazolopyrimidine compound, and preparation method and application thereof 上海医药集团股份有限公司 2024-03-01 CN disclosed
US-20240018124-A1 MODULATORS OF FPR1 AND METHODS OF USING THE SAME BIOFRONT LTD (KY) 2024-01-18 US disclosed
CN-116033897-A Phenol derivatives 住友制药株式会社 2023-04-28 CN disclosed
EP-3712147-B1 SGLTS INHIBITOR AND APPLICATION THEREOF SHANGDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2023-01-25 EP disclosed
CN-115246787-A Meta-disubstituted compound, preparation thereof and application thereof in preventing and treating mosquito and plant pathogenic bacteria 吉林省达凯生物医药有限公司 2022-10-28 CN disclosed
WO-2022050385-A1 PHENOL DERIVATIVE 大日本住友製薬株式会社 2022-03-10 WO disclosed
EP-3960741-A1 QUINOLINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF Academy Of Military Medical Sciences (CN) 2022-03-02 EP disclosed
US-10822365-B1 SGLTS inhibitor and application thereof SHANDONG DANHONG PHARMACEUTICAL CO., LTD. (CN) 2020-11-03 US disclosed
US-20200331950-A1 SGLTS INHIBITOR AND APPLICATION THEREOF SHANDONG DANHONG PHARMACEUTICAL CO., LTD. 2020-10-22 US disclosed
EP-3712147-A1 SGLTS INHIBITOR AND APPLICATION THEREOF Shangdong Danhong Pharmaceutical Co., Ltd. (CN) 2020-09-23 EP disclosed
EP-2094081-A1 TRICYCLIC HETEROAROMATIC COMPOUNDS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES Merck & Co., Inc. (US) 2009-09-02 EP disclosed
US-7425655-B2 Mono di &amp; tri cyclic compounds useful for lowering IgE concentrations THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2008-09-16 US disclosed
US-7425655-B2 Mono di &amp; tri cyclic compounds useful for lowering IgE concentrations THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2008-09-16 US disclosed
WO-2008060488-A1 TRICYCLIC HETEROAROMATIC COMPOUNDS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES MERCK & CO., INC. (US) 2008-05-22 WO disclosed
US-4466977-A N-[2-Amino(oxy- or thia- group-substituted-cycloaliphatic)]benzeneacetamides and -benzamide analgesics THE UPJOHN COMPANY (US) 1984-08-21 US disclosed
EP-0108602-A1 N-(2-aminocycloalkyl)benzamide and benzeneacetamide derivatives THE UPJOHN COMPANY (US) 1984-05-16 EP disclosed
US-4360531-A Substituted cycloalkanes THE UPJOHN COMPANY (US) 1982-11-23 US disclosed